Roberts Brigette
Chief Corp. Affairs Officer
DirectorOfficer
Latest Insider Transactions
8 transactions (past 365 days)
| 2026-06-11 | 2026-05-18 | QNCX Quince Therapeutics, Inc. | CCAO | Award | 34,675 | $0.09 | $3,121 |
| 2026-06-11 | 2026-05-18 | QNCX Quince Therapeutics, Inc. | CCAO | Award | 69,350 | $0.09 | $6,242 |
| 2026-06-11 | 2026-05-18 | QNCX Quince Therapeutics, Inc. | CCAO | Award | 124,830 | $0.09 | $11,235 |
| 2026-06-11 | 2026-05-18 | QNCX Quince Therapeutics, Inc. | CCAO | Award | 133,615 | $0.09 | $12,025 |
| 2026-06-11 | 2026-05-18 | QNCX Quince Therapeutics, Inc. | CCAO | Award | 228,855 | $0.09 | $20,597 |
| 2026-06-11 | 2026-05-18 | QNCX Quince Therapeutics, Inc. | CCAO | Award | 362,092 | $0.09 | $32,588 |
| 2026-06-11 | 2026-05-18 | QNCX Quince Therapeutics, Inc. | CCAO | Award | 2,070,107 | $0.09 | $186,310 |
| 2026-06-11 | 2026-05-18 | QNCX Quince Therapeutics, Inc. | CCAO | Award | 6,837,319 | $0.84 | $5,743,348 |
QNCX
CCAO
Award
$186.3K
2,070,107 shares @ $0.09
Filed 2026-06-11Trade 2026-05-18
Quince Therapeutics, Inc.